Caliway Biopharmaceuticals (Caliway) announced that the European Medicines Agency (EMA) granted Orphan Drug Designation (ODD) to its novel small molecule drug, CBL-514, for the treatment of Dercum's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback